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β-NTA  2-naphthoyltrifluoroacetone 
βHCG  The β-subunit of hCG gonadotropin 
ASSURED Affordable, sensitive, specific, user-friendly, rapid and robust,  
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S/N  Signal-to-noise 
SA  Streptavidin 




UCμP  Upconverting microphosphor 
UCNP  Upconverting nanophopshor 
UCP  Upconverting phosphor 
UV  Ultraviolet 
VIS  Visible 





Point-of-care (POC) –diagnostics is a field with rapidly growing market share. As 
these applications become more widely used, there is an increasing pressure to 
improve their performance to match the one of a central laboratory tests. Lanthanide 
luminescence has been widely utilized in diagnostics because of the numerous 
advantages gained by the utilization of time-resolved or anti-Stokes detection. So far 
the use of lanthanide labels in POC has been scarce due to limitations set by the 
instrumentation required for their detection and the shortcomings, e.g. low brightness, 
of these labels. Along with the advances in the research of lanthanide luminescence, 
and in the field of semiconductors, these materials are becoming a feasible alternative 
for the signal generation also in the future POC assays. 
The aim of this thesis was to explore ways of utilizing time-resolved detection or anti-
Stokes detection in POC applications. The long-lived fluorescence for the time-
resolved measurement can be produced with lanthanide chelates. The ultraviolet (UV) 
excitation required by these chelates is cumbersome to produce with POC compatible 
fluorescence readers. In this thesis the use of a novel light-harvesting ligand was 
studied. This molecule can be used to excite Eu(III)-ions at wavelengths extending up 
to visible part of the spectrum. An enhancement solution based on this ligand showed 
a good performance in a proof-of-concept -bioaffinity assay and produced a bright 
signal upon 365 nm excitation thanks to the high molar absorptivity of the chelate. 
These features are crucial when developing miniaturized readers for the time-resolved 
detection of fluorescence. 
Upconverting phosphors (UCPs) were studied as an internal light source in glucose-
sensing dry chemistry test strips and ways of utilizing their various emission 
wavelengths and near-infrared excitation were explored. The use of nanosized 
NaYF4:Yb3+,Tm3+-particles enabled the replacement of an external UV-light source 
with a NIR-laser and gave an additional degree of freedom in the optical setup of the 
detector instrument. The new method enabled a blood glucose measurement with 
results comparable to a current standard method of measuring reflectance. Microsized 
visible emitting UCPs were used in a similar manner, but with a broad absorbing 
indicator compound filtering the excitation and emission wavelengths of the UCP. 
This approach resulted in a novel way of benefitting from the non-linear relationship 
between the excitation power and emission intensity of the UCPs, and enabled the 





Vieritestaus on nopeasti laajeneva diagnostiikan osa-alue. Näiden sovellusten 
yleistyminen asettaa myös vaatimuksia niiden suorituskyvylle, jonka tulisi 
ideaalitapauksessa yltää keskuslaboratoriotestien tasolle. Lantanidien luminesenssia on 
jo pitkään hyödynnetty diagnostisissa sovelluksissa johtuen niiden lukuisista eduista, 
joita saavutetaan käytettäessä aikaerotteista tai käänteisviritykseen perustuvaa 
mittaustekniikkaa. Tähän asti lantanidileimojen käyttö vieritestauksessa on kuitenkin 
ollut vähäistä, johtuen niiden havainnointiin käytettyjen laitteistojen ja itse leimojen 
rajoituksista. Näissä tapahtuneen kehityksen myötä lantanidileimat ovat jo 
varteenotettava vaihtoehto entistä parempien vieritestien kehitykseen. 
Tämän väitöstyön tavoitteena oli tutkia tapoja hyödyntää aikaerotteista ja 
käänteisviritysmittaustapaa vieritestauksessa. Aikaerotteisen mittauksen vaatima 
pitkäikäinen fluoresenssi voidaan tuottaa lantanidikelaateilla, joiden viritys tapahtuu 
perinteisesti ultraviolettiaallonpituuksilla. Tämän virityksen tuotto on kuitenkin 
hankalaa vieritestaukseen soveltuvalla mittalaitteella. Tässä väitöstyössä tutkittiin 
uuden ligandin käyttöä Eu(III)-ionin virityksessä. Tutkitun ligandin viritysspektri ylsi 
näkyvän valon aallonpituuksille ja soveltui käytettäväksi bioaffiniteettimäärityksessä. 
Uusi kehitysliuos toimi hyvin mallina käytetyssä bioaffiniteettimäärityksessä ja tuotti 
voimakkaan signaalin 365 nm virityksellä johtuen kelaatin suuresta molaarisesta 
absorptiviteetista. Nämä ominaisuudet ovat keskeisiä, kun kehitetään vieritestaukseen 
soveltuvia, pienikokoisia mittalaitteita aikaerotteisen fluoresenssin mittaukseen. 
Käänteisviritteisiä partikkeleita puolestaan käytettiin sisäisinä valonlähteinä veren 
glukoosipitoisuutta mittaavissa testiliuskoissa, hyödyntäen näiden partikkelien lähi-
infrapunaviritystä ja lukuisia emissioaallonpituuksia. Nanokokoisten 
NaYF4:Yb3+,Tm3+-partikkeleiden käyttö mahdollisti ulkoisen ultraviolettivalonlähteen 
korvaamisen lähi-infrapunalaserilla ja mittalaitteen optisen kokoonpanon vapaamman 
suunnittelun. Uusi mittaustapa tuotti tuloksiltaan standardimenetelmään verrattavan 
suorituskyvyn. Mikrokokoisia, näkyvän valon aallonpituuksilla emittoivia 
käänteisviritteisiä partikkeleita hyödynnettiin vastaavalla tavalla, mutta käyttäen 
laajalla aallonpituusalueella absorboivaa indikaattoriyhdistettä, suodattaen sekä 
partikkelien emissio- että viritysaallonpituuksia. Tämä menetelmä mahdollisti uuden 
tavan hyödyntää näiden partikkelien viritys- ja emissiotehon välistä epälineaarista 





Point-of-care (POC) testing is an area of diagnostics that refers to a test performed 
near the patient or the treatment facility. This provides rapidly crucial information 
related to the treatment without the need to send the sample to a central laboratory. 
Various forms of POC testing are already used regularly, including measurement of 
blood glucose, pregnancy tests, and detection of markers for acute coronary syndrome. 
POC assays have been shown to have several benefits including reduced frequency of 
hospital visits, travel expenses, and lost work time.1 They can also improve clinical 
decision making, patient satisfaction, and adherence to prescribed medication.2,3 
Patients using POC tests are also more careful with their lifestyle4 and take a more 
active part in their treatment5. However, some applications require higher sensitivity6 
or a lower limit of detection than can be attained by the current methods7.  
Lanthanide chelates8 and upconverting phosphors9 have proven themselves as valuable 
luminescent label technology in various diagnostic applications. These labels have 
already shown a tremendous potential in some POC-applications as they can be used 
to improve the detection limit of the assays by utilizing time-resolved10,11 or anti-
Stokes detection12,13. Despite the promising results, the use of lanthanide labels in POC 
has been scarce so far, partially due to the lack of proper instrumentation10,11,14–16. 
However recent advances in light-emitting diodes (LEDs)17, detectors18, and 
photoluminescent lanthanide materials19,20 are now removing these obstacles. 
In this thesis, new ways of utilizing lanthanide labels in POC-assays have been studied 
by investigating the use of a new type of enhancement solution for Eu(III)-ions, that 
could potentially be used with a miniaturized reader. Upconverting phosphors have 
been studied as an internal light source in glucose sensing test strips. The following 
literary review will focus on providing an overview on the current POC technologies, 
their shortcomings, and on how lanthanide labels could be used to overcome them. 
The feasibility of utilizing lanthanide labels in POC assays is also discussed. 
Review of the literature 
12 
 
2 REVIEW OF THE LITERATURE 
2.1  Point-of-care –testing 
2.1.1 History 
The history of point-of-care testing can be said to trace a long way back into the 
history (1500 BCE), when it was discovered that ants were drawn to the urine of 
certain people. This may well have been the earliest method to diagnose glucose in the 
urine, a sign of diabetes. In the medieval times this technique was refined by having a 
physician taste the urine and look for the sweet taste of glucose. The English physician 
Thomas Willis first reported this method in 1674, describing the taste of diabetic urine 
as “wonderfully sweet as if it were imbued with honey or sugar”. Luckily for the 
physicians, chemical testing made the tasting unnecessary in the 20th century. The first 
tests were performed by heating urine with Benedict’s reagent, when the glucose in the 
urine would reduce the copper-ions in the solution and turn the colour from blue to 
red.21 
Further improvement came with the launch of Clinistix in 195622. These test strips 
utilized enzymes for a more specific reaction and there was no longer need to heat the 
urine. The results could be observed as a colour change on the test strips, but the 
results remained semi-quantitative at best. Urine remained as the sample material for 
long as it is easily accessible and easy to deal with. Despite these benefits, measuring 
glucose in urine is a rather insensitive and nonspecific method that only shows the 
elevation in blood glucose while hypoglycemia remains undetected. To account for 
these issues, the first test strips for detecting glucose in blood were developed already 
in 196423. Just like with test strips for urine, the method of detection was to observe the 
formation of colour on the strip and to compare this to a reference chart to estimate 
the amount of glucose in the blood. In order to improve the interpretation of the 
results, an instrument was introduced in 1969 to measure reflectance from the test 
strips24. Despite the testing getting rather easy to perform, most of it was still done in a 
hospital setting by professionals and the idea of letting the patients perform the tests 
themselves at home was a rather controversial issue21 until 197525. This was soon 
followed by the introduction of the first home pregnancy test in 197626. 
Self-monitoring of blood glucose was among the very first point-of-care test, and 
nowadays perhaps the most widely used one in the world with numerous other tests 
also available and new ones constantly under development. According to the BCC 
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Research LLC27, the rapidly growing POC market is expected to reach 19.3 billion US 
dollars by the year 2018 as a result of a rising number of lifestyle diseases and a trend 
towards healthcare decentralization. 
2.1.2 Benefits of POC-testing 
Despite the higher cost-per-test compared to a central laboratory testing, POC-assays 
can bring tremendous benefits to various areas of healthcare. In-home testing has been 
shown to reduce frequency of hospital visits, travel expenses, and lost work time1. 
POC-testing can also improve clinical decision making, patient satisfaction, and 
adherence to prescribed medication.2,3 Patients using POC tests are also more careful 
with their lifestyle (e.g. diet and alcohol consumption) and have a higher degree of 
compliance because they are more motivated4 and take a more active part in the 
treatment5. 
In order to evaluate POC tests, the world health organization (WHO) has listed a set of 
requirements that an ideal POC test should fulfill.28 These requirements are known by 
the acronym ASSURED, standing for: affordable, sensitive, specific, user-friendly, 
rapid and robust, equipment-free, delivered.29 
2.1.3 POC-technologies 
It should be noted that point-of-care is a very broad term and its definition has 
undergone some changes over the years, one of the latest being “a diagnostic test that 
is performed near the patient or treatment facility, has a fast turnaround time, and 
may lead to a change in patient management”30. The actual circumstances, where the 
testing is performed, may range from a modern hospital environment in a high-
income country with electricity and trained personnel available, to a rural area in a 
low-income country lacking electricity and trained personnel31. As also each analyte 
and sample matrix present their own requirements, there is no one-size-fits-all -
solution and different POC application can be divided into a wide spectra of 
technologies as done by Luppa et al32. They have divided the POC analysers into six 
categories based on their sensor characteristics, complexity, measuring mode, 
underlying detection principle and sample matrix. According to this classification, the 
POC tests span from rather simple lateral flow assays all the way to tremendously 
sophisticated lab-on-a-chip -type of solutions. The result may be a simple qualitative 
colour formation, interpretable with the naked eye, or a quantitative signal, requiring a 
dedicated reader. 
Review of the literature 
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Depending on the assay, the actual platform for a POC test can be e.g. a disposable 
strip, chip or a cartridge, that contains the necessary reagents, and possibly also 
fluidics, optics, electrodes etc. The sample matrix is preferably something easily 
obtainable, such as saliva or urine, but often also blood or other bodily fluid 
containing the analyte. One of the main challenges of the POC devices is the small 
sample volume usually something from hundreds of nanoliters to around a milliliter 
with analyte concentrations from femto- to millimolar.33  
2.1.4 Signal generation techniques 
Current methods 
Optical techniques are usually considered as the “gold standard” as the signal 
generation technique in POC assays34–36 and they are applied to several tests already on 
the market33. In comparison to the other market leader, electrochemical detection, 
optical methods may have a lower cost per test37, a greater aptitude for 
miniaturization31 and a better multiplexing capability37. 
As mentioned before, the interpretation of a result from a POC test may be a mere 
visual inspection of a line formed by e.g. gold nanoparticles38 on a home pregnancy 
test, or comparing the intensity of a formed colour to a reference picture as in early 
glucose test strips. This is without a doubt the simplest method as it requires no 
instrumentation for the detection33, but is not sensitive and precise enough for most of 
the applications. With a simple instrumentation to detect the absorbance or 
reflectance, it is possible to improve the interpretation compared to visual detection 
39,40. However, the small dimensions (e.g. on a microchip) pose severe problems for a 
sensitive and reliable absorbance measurement7. As the sample volume decreases, the 
optical path length through the sample decreases and this affects the measurement as 
described by the Beer-Lambert law. Several signal amplification strategies have been 
developed in order to overcome this issue utilizing noble metals41,42 nanoparticles, and 
enzymes41 with excellent results. However these methods generally require additional 
liquid handling steps increasing the time and work required. For assays such as lateral 
flow, label which give direct signal are preferable.43 
An example of a case where the current methods are starting to fall short are the blood 
glucose meters. They are generally based on detecting the enzymatic reaction with 
glucose either photometrically (by the change of colour) or amperometrically (by the 
electric current produced by the reaction). Many of these meters struggle to meet the 
limit of accuracy required6,44 and Rebel et al6 simply state that “Development of a 
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meter with accuracy equal to central laboratory devices should continue to be the 
industry goal”. 
Ways of improving assay sensitivity 
Several different optical technologies can be used in POC tests to improve their 
performance. These include, among others, fluorescence, chemiluminescence, surface 
plasmon resonance and light scattering.33 Each of these techniques has their 
advantages and drawbacks, and selecting the optimal one is often down to the specific 
application. Especially in the case of POC, it comes down to balancing cost, sensitivity, 
complexity, reproducibility, portability and power requirements.34 
Fluorescence is generally considered as the most popular technique requiring only a 
rather simple instrumentation producing a highly specific signal with detection limits 
down to 10-9-10-13 mol/L.36 It is the most widely used optical method for microsensing 
systems33 due to its superior selectivity, sensitivity and many colours available45,46. The 
conventional fluorophores still fall short of the label required for an ideal microfluidic 
device, defined by Gervais et al35, enabling the detection of analytes down to the 
concentration range of 10-12-10-15 mol/L. Many fluorophores also have issues such as 
high autofluorescence background, photobleaching, short luminescence lifetime, 
and/or toxicity. They also suffer from self-quenching, when the local fluorophore 
concentration is too high, e.g. when the labelling degree of a tracer molecule is too 
high. 
The single most prominent drawback affecting the assay sensitivity is the presence of 
an unspecific signal originating either from excitation light leaking to the detection 
window, or from autofluorescence. Autofluorescence originates from various sources 
including the sample vessel as well as the sample itself. A typical biological sample, e.g. 
serum, contains several fluorescent substances such as nicotinamide adenine 
dinucleotide (NAD+/H)47, and several plastics may pose issues for excitation 
wavelengths of up to 550 nm48. Due to autofluorescence, the detection limits of various 
labels are 50- to 1000-fold lower in a serum than in a buffer.49 Proper sample 
pretreatment can be used to minimize these problems, but it can be cumbersome50 and 
ideally also difficult matrices, such as whole blood, could be used for assays51. Several 
strategies have been employed to minimize the issue of autofluorescence, including the 
use of confocal optics52, two-photon excitation53, fluorescent labels with excitation and 
emission in the near-infrared (NIR) part of the spectrum54 or large Stokes shift55, 
modulating the analyte migration velocity and employing lock-in detection48, as well 
as optimizing the vessel material56. 
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Common features for these interferences are that they have a short or no lifetime 
(autofluorescence and leaked excitation light) and occur at higher wavelengths 
compared to the excitation. Lanthanide based labels have proven themselves 
interesting alternatives for the common fluorescent labels57,58 as they offer a convenient 
way to circumvent these issues with time-resolved or anti-Stokes detection. 
2.2  Lanthanide photoluminescence 
Lanthanides are a group of 14 elements with atomic numbers from 57 to 71 (from 
lanthanum to lutetium). These elements are extensively used in many modern 
applications including the production of renewable energy, electronics, and lighting. 
They are commonly also referred to as the rare earth elements, a name that stems from 
the misconception that these elements are extremely scarce. There is however a large 
variation in their rarity and some of the lanthanides are actually more abundant in the 
earth’s crust than all of the precious metals59. What makes lanthanides rare, is that they 
are rarely concentrated into ore deposits like most commercially mined metals60. 
Due to several applications, the global demand of lanthanides is expected to exceed 
160 000 tons in 2015, measured in rare earth oxides60. As the demand increases there is 
also an interest towards new mining processes with the environmental aspects taken 
into consideration61, as several cases of lanthanide mining have been associated with 
contamination of the local environment62. The value of luminescent lanthanide 
materials may be considered through the fact that, according to some estimations, in 
2012 luminescent materials account for one third of the commercial value of the 
annually extracted lanthanides, while representing less than 10 percent of their 
tonnage.19 
The remarkable properties of lanthanides originate from their electronic structure. 
They usually exist as trivalent cations giving them the electronic configuration of 
[Xe]4fn, where n represents the number of electrons in the 4f shells and varies from 0 
to 14 when moving through the lanthanide series from La(III) to Lu(III). The 4f 
orbitals are shielded by the 5s and 5p subshells63, which is the key to the chemical and 
spectroscopic properties of these ions. The chemical properties of lanthanides differ 
only slightly from each other due to their decrease in size along with the increasing 
atomic number64, making the separation of lanthanides challenging and costly65. 
What makes one lanthanide different from another, is their optical properties. Apart 
from lanthanum and lutetium, lanthanides have the ability to produce 
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photoluminescence in various wavelengths that cover the spectrum from ultraviolet 
(UV) to NIR66. These emissions originate from the transitions between the shielded 4f 
orbitals, which results in sharp bands with exceptionally long lifetimes67. The majority 
of the lanthanides have been employed as photoluminescent labels in diagnostics in 
one way or another, but a handful of these have received most of the attention. The 
diagnostic applications of these ions are divided into time-resolved fluorometry 
(utilizing mainly europium, terbium, dysprosium, and samarium) and upconversion 
(erbium, holmium, thulium, and ytterbium). 
The electronic transitions that take place between the 4f orbitals are so called Laporte-
forbidden transitions.67 This has two implications in terms of fluorescence. As the 
transitions are forbidden (or rather, have a low probability of occurring), the molar 
absorptivities of lanthanide ions are extremely low (< 10 M-1cm-1)68. Because of this, 
the direct excitation of lanthanides is an extremely unlikely event. However when the 
ion gets to an excited state, it may stay there up to millisecond timescale as also the 
relaxation is a forbidden process. The issue of excitation can be overtaken by placing 
the ion into an organic or inorganic environment containing excitation absorbers 
acting as antennas or sensitizers for the ion. The absorbed energy can then be 
transferred to the lanthanide ion. Placing the lanthanide ion in a ligand-field also 
disturbs its symmetry, partially relaxing the Laporte selection rule, making the 
transitions partially allowed.67 
The emission wavelength of the lanthanide is determined by the energy difference 
between the excited and ground state. The location of the states is determined by 
various forces affecting the electrons in the 4f-orbitals. As these electrons have very 
little interaction with the chemical environment of the ion, the energy states are 
determined by the interactions within the ion. The different states of the free ion are 
described by the Russell-Saunders69 term symbol 2S+1LJ, where 2S+1 represents the total 
spin multiplicity giving the number of possible electron spin orientations, L the total 
orbital angular momentum and J the total angular momentum of the f electrons. The 
repulsion between the electrons within the f-orbitals has the most impact on the 
energy level of each state designated by the term 2S+1L. These states are further split into 
J-levels by the spin-orbit coupling. The splitting caused by the ligand-field is one order 
of magnitude smaller than the effect of the spin-orbit coupling and appears merely as a 
fine structure of the individual band, often ignored.64 
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2.3  Lanthanide chelates 
2.3.1 Adjusting the excitation wavelength of Eu(III) chelates 
The classical excitation pathway 
The excitation of Eu(III) using an organic ligand as a light harvesting complex was 
originally reported by Weissman already in 194270. The use of europium as a label in 
immunoassays was suggested by Wieder71 and then by Soini and Hemmilä49. The first 
application of the DELFIA (dissociation-enhanced lanthanide fluoroimmunoassay), 
the most successful lanthanide-based immunoassay system reported to date, was 
finally published in 198372. Since then several lanthanide ions have been used in 
bioanalytical applications73, but Eu(III) is by far the most common58. 
The most common energy transfer pathway for the excitation of lanthanides with 
organic ligands is through the triplet pathway (1S -> 3T -> Ln) (Figure 1). In this 
pathway the ligand is first excited to the singlet state (1S), originating from the 
aromatic transitions (π -> π* or n -> π*) of unsaturated structures of the ligand with a 
high molar absorptivity (104-105 M-1*cm-1)74,75. The energy is then transferred through 
an intersystem crossing to the triplet state (3T) of the ligand from where the energy 
transfer to the lanthanide ion happens.67 In the case of e.g. DELFIA system, the 








Figure 1. Schematic representation of energy absorption (upward solid arrows), migration 
between energy states (dotted arrows), transfer to lanthanide (dashed arrows) and emission 
(downward solid arrows) processes in a lanthanide complex. 1S = singlet state, 3T= triplet state, 
1ILCT = singlet intraligand charge transfer state, LMCT = ligand-to-metal charge transfer state. 
Ligand fluorescence, phosphorescence, and non-radiative relaxations have been omitted for the 
sake of clarity. Adapted from76,77. 
Excitation in the UV-range, however, has certain downsides to it. Many materials are 
not transparent in the UV-range and thus cannot necessarily be used with these labels. 
The UV absorption may also lead to high levels of autofluorescence, and damage 
especially biological sample material. Also a pulsed UV-excitation, suitable for the 
excitation of fluorescent labels, can be rather cumbersome to produce. This is usually 
done with a xenon flash lamp operating at a high voltage. These lamps produce an 
extremely wide range of wavelengths, extending from the far UV to IR, which is 
excessive for the purpose of fluorescence excitation, as only a small fraction of the 
light, produced by the lamp, is utilized and the rest will have to be filtered out. 
Nitrogen lasers are an alternative excitation source, but they are expensive, suffer from 
low repetition rate and have to be shielded as they produce electromagnetic 
interference.78 Some excitation sources and detectors may also require additional 
choppers79. 
Light emitting diodes (LEDs) offer an interesting alternative as an excitation source. 
As they are small, cheap, and produce a rather narrow emission with a low voltage, 
they would enable the construction of significantly simpler and cheaper fluorescence 
readers. Unfortunately, LEDs that are powerful enough to be used as an excitation 
source, are available at wavelengths starting from 365 nm.80 In order to use LEDs as an 
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excitation source several new ligands have been developed that enable the excitation of 
europium at longer wavelengths. These will be presented in the following paragraphs. 
The theoretical maximum excitation wavelength for the triplet pathway is estimated by 
Steemers et al81 to be 385 nm due to the certain energy differences required between 
the different states to prevent back transfer of the excitation energy.81 Generally, the 
excitation wavelength can be shifted longer by expanding the π-conjugated system of 
the antenna ligand. Even though the location of the singlet state is of main interest 
when tuning the excitation wavelength of a lanthanide chelate, equally important in 
the triplet pathway is the location of the triplet state as it has a tremendous impact on 
the quantum yield of the complex82–84. Utilizing the triplet pathway, chelates that have 
excitation extending far beyond the theoretical maximum of 385 nm, to 400 nm85,86 
and even up to 500 nm87–89 have been reported. These compounds are generally 
fluorinated β-diketonates with a highly conjugated aromatic moiety. 
Energy transfer directly from the singlet state to the lanthanide (1S -> Ln) has also  
been studied intensively90–93, however the efficiency of this pathway is low because of 
the competing processes such as ligand fluorescence, non-radiative relaxation, and 
intersystem crossing94. 
Excitation through charge transfer states 
In addition to the triplet state, various other states of the ligand and the lanthanide 
may take part in the energy transfer process (Figure 1). These include two different 
charge transfer (CT) states, namely intraligand CT state (ILCT) and ligand-to-metal 
CT state (LMCT). These states can either work as pathways when energy, absorbed via 
singlet state, is transferred to the lanthanide, or they can work as energy absorbers. 
ILCT is an electron transfer process that occurs within the ligand. The ILCT state 
generally has high absorptivity with excitation wavelengths up to 485 nm. This 
pathway produces also higher quantum yields compared to several other excitation 
pathways utilized for europium chelate complexes.66,95,96 However, the sensitization of 
Eu(III) through ILCT was not recognized until 200493 and many of the previous 
studies may be falsely interpreted as merely an exceptionally small singlet-triplet gap97. 
Since then several studies regarding the role of ILCT in the excitation of Eu(III) have 
been published95,98–103. In order to obtain the charge transfer, these ligands often have a 
strong electron donating group, such as an amino moiety connected by a conjugated 
structure to the lanthanide binding part of the ligand102. 
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The LMCT state can be considered as a hybrid state from the mixing of ligand and 
lanthanide orbitals94. As the LMCT state tends to overlap with other states, it can be 
difficult to detect104. For example, a chelate with dpt-ligand (2-(N,N-diethylanilin-4-
yl)-4,6-bis(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine)) was reported to display a direct 
energy transfer from the ligand singlet state to the lanthanide93. Later it has been 
reported, that a LMCT state may also be involved in this process94. The LMCT state is 
essential when sensitizing lanthanides in inorganic compounds19, however, in 
lanthanide chelates it is more commonly known as a source for quenching90,105–108. 
LMCT can play a role in the migration of energy from the ligand singlet state to the 
lanthanide76,94 and direct absorption of LMCT has also been demonstrated, though the 
absorptivity was rather low101,105.  
Using d-metal complexes as antennas 
A rather new approach is to use d-metal complexes as energy absorbers by utilizing the 
metal-to-ligand charge transfer (MLCT). These ligands have moieties for binding the 
lanthanide, and the d-metal ion on the same complex. The energy is absorbed by the 
singlet charge-transfer state of the d-metal ligand complex (1MLCT) and transferred to 
the lanthanide via triplet state (3MLCT). These complexes have several advantages 
over the traditional ligands such as low energy triplet states, relatively high intersystem 
crossing quantum yield from the singlet to triplet state and a rather long triplet excited 
state lifetime improving the energy transfer to the lanthanide.66,109,110 Several d-metals 
have been utilized in the sensitization of lanthanides including Ru111–113, Os114 and 
Re115–118. However, only Ir119–121 and Pt122,123 have energy states suitable for the 
excitation of Eu(III) at wavelengths extending up to 500 nm110. 
Generally it can be noted, that the ligand triplet states (either 3T or 3MLCT) are the 
preferable donor states, when transferring the excitation energy to the lanthanide ion. 
As these states have longer excited state lifetime than singlet states (e.g. 1S or 1ILCT), 
the energy transfer is more likely to occur.19 
Suitability for aqueous solutions 
The majority of the studies regarding the energy transfer processes in lanthanide 
chelates are carried out in organic solvents as water is an efficient quencher of 
lanthanide luminescence. However, as practically all diagnostic assays are performed 
in an aqueous solution, the lanthanide chelates should be functional also in the 
presence of water. 
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Despite the difficulties presented by water, chelates with excitation extending up to 
400-450 nm have been reported97,124–127. Due to the quenching effect of water128, 
quantum yields of these complexes vary between 1 and 20 %, which is significantly 
lower than the highest reported value of 79 %89 measured in solid state. In comparison, 
the DELFIA Enhancement Solution has an overall quantum yield of 70 %129 and many 
organic fluorophores reach even higher numbers (e.g. fluorescein 85 %130). 
2.3.2 Lanthanide chelate containing particles 
Thanks to the elimination of autofluorescence, lanthanide chelates usually provide 
excellent sensitivity in bioaffinity assays despite their low brightness compared to 
many other fluorophores. However, when constructing miniaturized readers, the 
power of the excitation source (e.g. LEDs) and the sensitivity of the detector (e.g. 
photodiodes) are generally lower than in larger tabletop readers. Therefore, the 
brightness of an individual chelate may not be high enough to be efficiently detected 
and the signal of an individual label has to be increased. 
Packing lanthanide chelates in nanoparticles produces labels with high brightness as 
one particle can accommodate thousands of chelates. Because of the wide Stokes shift 
of the chelate, they are not self-quenched despite the high local concentration.131 The 
particle also protects the chelates from interaction with the environment132, including 
the quenching effect from water133 and some serum components134. This can be a 
valuable feature in homogenous assays where no washing steps are performed. The use 
of particles has produced excellent results also with chelates excitable at the visible 
wavelengths. Several monodispersed particles with excitation at the visible range have 
been reported135–139 with quantum yields of 31 % and excitation up to 475 nm139. 
2.3.3 Applications of time-resolved fluorometry in diagnostics 
General principle 
The long lifetime of lanthanide fluorescence can be utilized in diagnostics to eliminate 
the nonspecific background signal originating from autofluorescence with time-
resolved detection, provided that the lifetime of the lanthanide emission is at least 10 
times longer than the one of the background signal49. In practice the measurement is 
performed with a pulsed excitation followed by a delay, during which the 
autofluorescence (from various sources e.g. plastic and organic material) has time to 
drop down to a negligible level, before the signal collection is started (Figure 2). 
Practically all of the emission detected in this time-window originates from the 
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lanthanide label providing excellent detection limits, which broadens the linear range 
of the assays due to the low background signals.58 
 
Figure 2. The principle of the time-resolved fluorescence measurement. 
The first utilization of europium ions in bioaffinity assay was based on the use of an 
enhancement solution for heterogeneous assays, commercialized under the name of 
DELFIA by Wallac Oy. In this technique the lanthanide ion is bound to the detector 
molecule with a carrier ligand, that forms a non-luminescent complex with the 
lanthanide ion. When the bioaffinity reaction is completed, the ion is released from the 
carrier ligand and bound by the antenna ligand in a micellar chelating environment. 
This technique has been later refined to work also in the presence of disturbing 
agents140 and the PerkinElmer Citations Library141 reveals well over 300 publications 
related to DELFIA. 
Due to the release of the lanthanide ion, this technique can’t be utilized in applications 
where the signal has to be localized (e.g. imaging and flow cytometry), or where the 
signal has to be obtained before the reaction endpoint (e.g. real-time PCR). Therefore, 
a large number of intrinsically fluorescent chelates have been developed to address this 
issue142–147. They enable the use of lanthanide fluorescence in several assay technologies 
such as simpler heterogeneous assays148, real-time PCR149, various homogeneous 
bioaffinity assays150,151, and lanthanide-based probes152. 
POC application 
Few commercial applications related to the use of lanthanide chelates in point-of-care 
–diagnostics have been introduced so far. These are the AQT90 FLEX –
immunoanalyzer153,154 from Radiometer Medical ApS and GenomEra-system155–158 
from Abacus Diagnostics Oy. Both of these platforms are based on an automated 
tabletop analyzer that analyses the sample with minimal pretreatment. Several tests are 
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available including cardiac troponin I and T, creatine kinase MB (CKMB), myoglobin, 
NT-proBNP (N-terminal of the prohormone brain natriuretic peptide), CRP (c-
reactive protein), βhCG (human chorionic gonadotropin) and D-dimer from whole 
blood and plasma for the AQT90 FLEX and methicillin-resistant S. aureus, C. difficile, 
Streptococcus B and pneumoniae from various sample materials for the GenomEra. 
One of the most common point-of-care –technologies are the lateral flow assays, and 
the use of nanoparticles embedded with Eu(III)-chelates as a label with this technology 
has been widely studied and assays for eosinophiles and neutrophiles15, C-reactive 
protein159, prostate spesific antigen10, and P. stewartii11 have been published. Generally 
nanoparticles with Eu(III) are highly suitable for lateral flow assays and improvements 
on the assay sensitivities, in comparison to gold nanoparticles, have been reported10,11. 
Juntunen et al10 also concluded that, due to the large Stokes shift of Eu(III)-chelates, a 
good assay performance was achieved even with only pulsed detection and continuous 
detection. 
Several publications have been underlining the benefits of Eu(III)-chelates160,161 and  
-nanoparticles162,163 in POC immunoassays, and presented new technologies to be used 
with them, such as the chelate complementation164. Eu(III)-chelate embedded 
nanoparticles have been utilized on microchip immunoassays to produce high enough 
signal without the need for enzymatic signal amplification14. Some examples from the 
limits of detection obtained with europium labels can be found from e.g. the work of 
Pettersson et al160. They present an assay for C-reactive protein using Eu(III)-chelates 
as a label, with a limit of detection of 0.01 mg/L. Hyytiä et al165 on the other hand have 
reported an assay for cardiac troponin I utilizing Eu(III)-nanoparticles with an 
impressive limit of detection of 0.41 ng/L. However, a significant drawback in the 
utilization of lanthanide chelates and nanoparticles in POC devices, is the lack of a 
compact reader10,11,14,15. 
2.3.4 Instrumentation used for the detection of Eu(III)-chelates 
It is already possible to benefit from lanthanide chelates with a tabletop analyser as 
they can accommodate the traditional bulky components needed for the time-resolved 
detection of lanthanides, and they are plugged to an electric outlet that satisfies the 
power requirements of these components. For assays, such as lateral flow, a hand-held 
reader is often a crucial requirement and it is not feasible to fit the commonly used 
components (xenon flash lamp and photomultiplier tube), in a battery-operated, 
portable device. 
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Excitation of Eu(III)-chelates with LEDs has been reported on few occasions, such as 
on a temperature sensor based on Eu(III)-chelate in a polymer film166,167. The chelates 
in question had excitation spectra extending up to 425 nm and a quantum yield of 40 
% (under 405 nm excitation in toluene at 25 °C). The chelates were efficiently excited 
with LEDs up to 450 nm167 (the output power of the LEDs was not reported). LED-
excitation of Eu(III)-chelates has also been studied in flow cytometry168 and time-
resolved microscopy169–171. In flow cytometry a 100 mW LED emitting at 365 nm was 
used to detect Giardia lamblia cysts with Eu(III)-chelate as a label. The chelate in 
question had an excitation maximum at 340 nm, extending up to 380 nm (the 
quantum yield was not reported)172. Similar Eu(III)-chelates and nanoparticles169–
171  were used for imaging, utilizing also a 365 nm LED as an excitation source, that 
proved to be a potential option for a traditional flash lamp171. However, all of these 
studies have used a photomultiplier tube or a bulky CCD-camera (charge-coupled 
device) as a detector, which means they are by no means small and portable. 
Many groups have also attempted to construct their own miniaturized readers to 
detect Eu(III)-nanoparticles on lateral flow test strips11,15,159, but this area of research 
seems to be shrouded in mystery as, despite the claims of excellent results, details are 
usually not reported. Photodiodes are generally considered as light detectors for 
miniaturized fluorescence readers. Rundström et al15 report to have used the 
combination of 385 nm LED and photodiode with Eu(III)-nanoparticles on lateral 
flow strips, with a detection limit of 3.3*107 particles/mm2. The particles in question 
had a diameter of 120 nm and an excitation maximum around 340 nm131. No further 
details regarding the instrument are mentioned. Song and Knotts159 have reported that 
a 365 nm LED was not powerful enough for their application using commercial 
Eu(III)-particles. Unfortunately, they have not revealed further details about the LED 
or the label. Zhang et al11 claim to have developed a compact and sensitive reader. 
However, no details about the reader have been reported. 
Despite the many drawbacks of the photomultiplier tubes (cost, high voltage, lack of 
robustness), they are still the most sensitive detector available despite the advances 
made with photodiodes. Recently a device called micro photomultiplier tube has been 
introduced by the company Hamamatsu Photonics. This device is marketed as one to 
have the sensitivity of a PMT but being extremely small and also suitable for portable 
POC-applications. However, as this component has just been introduced, no 
publications regarding its performance have yet been published. 
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2.4  Upconverting phosphors 
2.4.1 Theory of upconversion and upconverting materials 
General background 
Upconversion (also known as anti-Stokes photoluminescence) is a mechanism where 
the energies of two or more low energy excitation photons (generally near-infrared) 
are combined to produce one emission photon with higher energy. This is made 
possible by the ladder-like distribution of long-lived energy levels of certain lanthanide 
ions. With modern upconverting materials it is possible to produce various emissions 
ranging from UV- to NIR-range with a 980 nm excitation.173 Upconverting phosphors 
(UCPs) are inorganic particles consisting of a lattice, doped with the emitter ion 
(activator). Usually also sensitizer ions are used in conjunction with the activators. 
It is also possible to produce anti-Stokes fluorescence through multiphoton 
absorption174 or triplet-triplet annihilation175. However, the multiphoton absorption 
requires a high power (106-109 W/cm2) pulsed excitation source, whereas relatively low 
power (1-103 W/cm2)176 is enough for the UCPs. This can be easily produced with a 
low cost laser diode.177 The triplet-triplet annihilation requires low excitation power 
(~10 W/cm2)175 and has attracted much attention to be used in solar cells178, but so far 
no diagnostic applications have been reported. 
Theoretically, most lanthanide ions can produce upconversion when embedded in an 
inorganic lattice173, but the most efficient activators are Er(III) and Tm(III)179. These 
two ions produce also a wide variety of emissions, and it is possible to cover most of 
the spectrum from UV to NIR wavelengths with them (Figure 3). Ho(III) can be 
occasionally encountered in some applications. It has an emission spectrum relatively 
similar to Er(III), but a lower efficiency so it is not as widely used. 




Figure 3. The anti-Stokes emissions of Er(III) (solid line) and Tm(III) (dashed line) under 980 
nm excitation cover a wide range of wavelengths. The spectra are adapted from Vuojola et al180 
(NaYF4:Yb3+,Er3+) and Kale et al181 (NaYbF4:Tm3+). 
The sensitizer ion is used to harvest the excitation energy and to transfer it non-
radiatively to the activator. This can be considered analogous to the use of an antenna 
ligand in lanthanide chelates as discussed in the previous chapter. Ytterbium is a 
common sensitizer ion as it conveniently has only one excited state, which matches 
well with the different energy levels of the activators. For a lanthanide, ytterbium has a 
relatively large absorption cross-section of 11.7*10-21 cm2 that is about an order of 
magnitude larger than that of erbium182. However, this is still between four and five 
orders of magnitude lower than the antenna ligands used with lanthanide chelates. 
Therefore, ytterbium is commonly used in relatively large concentrations and the 
doping content is usually around 20 mol-%176. Some studies have gone a lot further 
and dopant levels up to 98 mol-% have been reported183. 
Optical processes leading to upconversion 
The use of an activator is more or less an assumption when producing efficiently 
upconverting particles. This enables the production of upconversion through a process 
called the energy transfer upconversion (ETU) (Figure 4). It is possible to produce 
upconversion also without the sensitizer ion through a process called the excited-state 
absorption (ESA).176 This process refers to a sequential absorption of two excitation 
photons by a single activator ion. Even though the long lived excited states of the 
lanthanide ions make this possible, the excitation power required is still too high for 
many practical applications and it is less efficient than the ETU by about two orders of 
magnitude.184 




Figure 4. Proposed energy transfer mechanisms in Yb(III)-Er(III) and Yb(III)-Tm(III) pairs, 
under 980 nm excitation. Solid upward arrows represent excitation, dashed arrows energy 
transfer processes, dotted arrows relaxations and solid downward arrows emissions. Adapted 
from Dong et al176. and Sun et al185. 
Excitation and emission wavelengths of UCPs 
When a sensitizer ion is used to absorb the excitation, it mainly determines the 
excitation wavelength of the UCP. In the case of ytterbium, this is roughly 980 nm. 
However, this is not the optimal wavelength to all of the applications since water has a 
relatively high absorption in that region and can cause heating when a high intensity 
excitation is applied186. Therefore the use of Nd(III) as an additional sensitizer together 
with Yb(III) has also been studied186–189. As Nd(III) can be excited at 808 nm, 
absorption of water is 24 times lower than at 980 nm186. 
The locations of the emission peaks of UCPs are determined by the activator ion, but 
the ratios of the different emissions and the overall luminescence quantum yield of the 
particle depend on various parameters. The lattice, while optically inert, plays a crucial 
role in determining the upconversion efficiency. Several materials have been studied 
for this9, but so far β-NaYF4 is considered the best host material to produce 
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upconversion190,191. In addition to this, the particle size, and ion doping concentrations 
all affect the UCP emission192. 
The effect of particle size on UCP emission 
A lot of effort has been put into making UCPs as small as possible, as sub-10 nm 
particles are preferable to bioimaging applications193. Such particles have been 
synthesized194–196 but, as mentioned previously, particle size has a large impact on the 
emission properties of an upconverting phosphor. As the size of the particle decreases, 
the surface area to volume –ratio increases and the surface effects become critical at 
diameters under 20 nm194. Therefore a relatively higher number of surface defects and 
a higher ratio of the optically active ions that are exposed to the environment. Both of 
these can result in non-radiative transitions that quench the UCP emission195,197. More 
specific studies have shown that both the UCP quantum yield198 and emission 
lifetimes194,196,199 decrease with the particle size. Protecting the particles with a shell of 
undoped lattice material has commonly been used to overcome these issues194–196,200,201. 
Gargas et al194 have determined that for UCPs with a diameter of 8 nm, the optimal 
shell thickness is about 1.8 nm. These core-shell structures have also been used in 
various ways to enhance the emission and to tune the optical properties of UCPs.20,202 
Drawbacks of UCPs 
There is also a good reason to study ways of enhancing the emission intensity of UCPs 
as the low brightness is a common drawback. The reported absolute quantum yields of 
NaYF4:Yb3+,Er3+ particles vary between 0.0022-3.5 %196,198 depending on the particle 
size (<10 nm to bulk) and dopant concentrations. It should be noted, that opposed to 
traditional fluorophores, the theoretical maximum quantum yield of UCPs can never 
be 100 %. As upconversion is a multiphoton process, a rough number would be 100 
%/n, where n is the average number of excitation photons required to produce one 
emission photon. This is still not taking into account a significant portion of the 
excitation photons lost as down shifting emission.203 Only few results have been 
reported so far as the non-linear nature of upconversion makes the measurement and 
comparison of these results rather complicated, as the UCP quantum yield depends 
also on the excitation intensity. 
As the light harvesting ability of lanthanides is limited by the low absorptivity, 
attempts have been made to overcome this by using organic infrared dyes as antenna 
molecules with UCPs. This approach also broadens the excitation spectrum to the 
shorter wavelengths. With this approach, Zou et al204 managed to increase the 
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integrated spectral response of the UCPs 3 300-fold. Plasmonic field enhancement has 
been studied in various ways205 with upconversion enhancement up to 450-fold. 
In order to conjugate infrared dyes or binder molecules on the UCP, proper functional 
groups will first have to be introduced on the particle surface. This modification step is 
required also to render the particles dispersable in aqueous solution, as the particles 
are generally coated with hydrophobic ligands after the synthesis. Several methods 
have been developed for this and a recent review from Sedlmeier and Gorris gives an 
excellent overview on the topic206. 
Even though the synthesis methods have excellent control over particle size207 and over 
size distribution208, the issue of batch-to-batch variation remains as an issue9. The 
thermal decomposition method is perhaps the most common way of synthesizing e.g. 
the monodispersed NaYF4-particles with excellent control over particle size207–209. This 
method is based on adding the organometallic precursors to a hot solvent that triggers 
their thermal decomposition and releases the reactants causing a rapid nucleation 
burst. The surface ligands coordinate to the growing particles and control their growth 
by blocking the expansion of the lattice9. The method however requires stringently 
controlled reaction temperatures, air-sensitive and expensive precursors, and an inert 
atmosphere. As the temperature range for the thermal decomposition is rather narrow 
(10 °C), it poses a significant challenge to the reproducibility9. 
2.4.2 Applications of upconverting phosphors in diagnostics 
Applications in general 
Upconverting phosphors have several features that make them an interesting label 
technology to be used in in vitro diagnostics. Features such as penetration depth of the 
NIR excitation210, highly specific signal free from autofluorescence211, resistance to 
photobleaching, non-blinking212 narrow emission bands, large anti-Stokes shift, and 
long-lived luminescence are features that can be beneficial in the development of 
various types of assays. 
UCPs were first utilized in a bioaffinity assay by Wright et al in 1997213 when they were 
used as a label in a sandwich assay to detect Staphylococcal enterotoxin B. The first 
imaging applications emerged in 1999214 when Zijlmans et al used UCPs as a marker 
for prostate specific antigen in tissue sections and CD4 membrane antigen on human 
lymphocytes. Van de Rijke et al reported a DNA array in 2001215 that also 
demonstrated the superior sensitivity of UCPs compared to a Cy5 –label. All of these 
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studies utilized particles composed of Y2O2S:Yb3+,Er3+ or Tm3+, that would be 
considered rather bulky by current standards  (200-400 nm in diameter). 
Despite the crude materials, new applications were developed, such as a protein array 
by Lu et al in 2004216 that utilized slightly smaller (80-150 nm) NaYF4:Yb3+,Er3+-
particles, that had a magnetic core to demonstrate the preparation of multifunctional 
particles. Also a multianalyte immunoassay217 and DNA genotyping218 arrays have 
been reported using significantly smaller (25 nm in diameter) NaYF4:Yb3+,Er3+ –
particles. 
The first homogenous assays, based on energy transfer with the UCP-particle as a 
donor, were published almost simultaneously by two different groups in 2005. Wang 
et al reported a sandwich assay for avidin that was based on the quenching of the UCP 
emission through an energy transfer to gold nanoparticles219 using 50 nm 
NaYF4:Yb3+,Er3+. Kuningas et al220 on the other hand demonstrated the excitation of B-
phycoerythrin through an UCP-particle in a competitive assay for biotin. These 
particles were bead-milled La2O2S:Yb3+,Er3+ and Y2O2S:Yb3+,Er3+ with an average 
diameter of 300 nm. This assay was further refined as an assay for the detection of 
estradiol in serum221 and finally in whole blood222. Other examples of using UCPs as a 
donor in homogenous assays based on energy transfer include the detection of siRNA 
in live cells223, enzyme activity assay180 and a dual parameter sandwich assay for the 
detection of nucleic acids224. In addition to fluorescent proteins, gold, organic 
fluorophores, various acceptors, such as carbon nanoparticles225, graphene oxide226 and 
quantum dots227 have been utilized in homogeneous assays with UCPs. 
Chemical sensors are also a common way of utilizing UCPs and applications e.g. for 
sensing pH228, carbon dioxide229, ammonia230, mercury231, cyanide232, temperature233 
and chromium234 have been reported. UCPs have also been utilized in the monitoring 
of enzymatic reactions through the modulation of their emission with common 
cosubstrates and coenzymes235,236. Many of these applications take advantage of the 
several emission peaks of UCPs to provide an internal control signal and, instead of 
using a single emission intensity, calculate the ratiometric signal between two emission 
peaks.230–233,236 
Applications in POC 
Many of the homogeneous assays utilizing UCPs are already aimed at POC testing e.g. 
measurement in whole blood51,222. This is made possible by the penetration depth of 
the NIR-excitation and the transparency of whole blood237 in the region where the red 
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emission of erbium can be used to excite an acceptor without any autofluorescence 
from the UCP excitation in the measurement window. 
One analyte that is of a particular interest in POC is the measurement of glucose. It has 
traditionally been tested with test strips utilizing enzymes238, but a general goal is to 
develop continuous glucose monitoring sensors239. With specific glucose binders, such 
as concanavalin A240 and boronic acid derivatives241, the development of also enzyme-
free assays is possible. Competitive homogeneous assays for glucose have been 
developed with an UCP as a donor and graphene oxide226 or gold nanoparticle242 as a 
quencher. Both of these assays utilize 50 nm NaYF4:Yb3+,Er3+-particles and use the 
quencher to modulate the 547 nm emission of the UCP in human serum. Del Barrio et 
al243 have constructed an enzyme-based sensor in a poly(acrylamide) film that uses a 
glucose oxidase cofactor flavin adenine dinucleotide to modulate the 475 nm emission 
of 26 nm NaYF4:Yb3+,Tm3+-particles, used to excite fluorescein linked to the glucose 
oxidase enzyme. 
He and Liu244 have utilized the homogenous assay principle of modulating the 547 nm 
emission of dendritic NaYF4:Yb3+,Er3+ UCP-particles using a tetramethylrhodamine or 
a graphene oxide as an acceptor to attenuate the UCP emission. Their proof-of-
concept assay detected the presence of matrix metalloproteinase-2 and 
carcinoembryonic antigen on a test strip composed of normal office paper. UCP 
proved to be an ideal photoluminescent label to be used with paper as the anti-Stokes 
detection circumvents the issue of high autofluorescence arising from fluorescent 
whitening agents in many commercial paper types. 
The area of POC, where the highest number of applications for UCPs have been 
developed, is the lateral flow type of sandwich assays. This technology has been applied 
in the detection of circular anodic antigen245,246, antibodies247–250, bacteria251–253, 
viruses254, cytokines248,255,256, and nucleic acids12,13,250,257–261. Comparison to an ELISA 
(enzyme-linked immunosorbent assay) has shown improved sensitivity246,255 up to 100-
fold251. Likewise comparison of UCP to colloidal gold on lateral flow assay has shown a 
100-fold improvement12. Even though non-competitive assay format is often used, also 
competitive assay for drugs of abuse has been demonstrated253. For samples requiring 
pretreatment prior to detection with a lateral flow (LF) strip, various types of 
microfluidic devices have been combined with the LF strips250,257–262, some of them 
specially designed for resource-poor settings, requiring no electricity263,264. 
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When combined with a pre-amplification step with a PCR, a lateral flow assay with 
UCPs as a label has been able to detect human papillomavirus (HPV) DNA in a 
sample containing down to 2000 copies of HPV per 10 ng of total DNA. The 
sensitivity of the UCP-label made it possible to limit the number of PCR cycles to 
prevent artifacts arising from extended amplification.12 The detection of infections 
without the amplification of DNA has also been studied with a detection limit of 106 
bacterial cells.13 This result is in line with a sandwhich assay for circular anodic 
antigen, that has a detection level between 105 and 106 target molecules per LF strip.246 
Different ways of realizing a multianalyte assay with these tests have also been 
demonstrated. The most common method is, as usually for lateral flow assays, to use 
several test lines on a single strip248,253,254,256. As UCPs with different activator ions can 
be excited with a single excitation source, the use of two UCPs with different emission 
wavelengths has also been demontrated265. An interesting, and quite flexible, form of 
multiplexing was also to use a plastic holder to incorporate 10 lateral flow strips in 
order to simultaneously distribute a single sample to all of them266.  
Even though UCPs have been utilized in several lateral flow studies, very little 
attention has been paid to the particles themselves in these studies. A majority of the 
studies have used Y2O2S:Yb3+,Er3+-particles267 with an average diameter of 400 nm and 
NaYF4:Yb3+,Er3+ with an average diameter of 250 nm266. Only one study has compared 
the large Y2O2S-particles to ten-fold smaller NaYF4:Yb3+,Er3+ with a diameter of 40 nm 
in a lateral flow assay. The authors didn’t find a significant difference between the 
performance of different particles and simply concluded that the smaller ones might 
be slightly better.268 
2.4.3 Instrumentation for detecting UCPs 
So far the lack of commercially available readers has been a significant drawback for 
UCPs and may have had a significant impact on the interest towards this technology. 
Gnach and Bednarkiewicz16 have speculated that “The upconverting nanophosphors 
(UCNP) could have gained the same impact on biosciences as quantum dots had, if 
only the UCNPs could be accessible to broader bio-scientific community early enough, 
and, what is equally important, the commercial imaging instrumentation is available.” 
A commercial reader called UpLink269 from OraSure Technologies was briefly 
available, but has been discontinued. This device was classified as portable and 
equipped with a 1 W IR-laser for the excitation of the UCPs and a photomultiplier 
tube (PMT) for the detection. A Finnish company Labrox Oy has recently launched a 
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commercial instrument for UCP detection, named as the Upcon Reader. This is a 
multifunctional microtiter plate reader, equipped with a 2 W 976 nm laser and a 
photomultiplier tube, everything packed in the dimensions of 200 x 268 x 495 mm 
weighing 13 kg. It can also be equipped with a 10 W xenon flash lamp for the 
measurement of absorbance, luminescence, fluorescence, time-resolved fluorescence, 
and fluorescence polarisation in addition to upconversion 
The advantage of quantum dots, mentioned by Gnach and Bednarkiewicz16, is the 
ability to use existing instrumentation for fluorescence detection, equipped with a 
standard broadband excitation source such as xenon lamp. Ironically, the 
instrumentation needed for the detection of UCPs is rather simple and in some cases 
the NIR-radiation from a 75 W xenon-lamp has been sufficient, even though not 
optimal, for the excitation of larger (400 nm in diameter) UCPs214,215. In comparison to 
europium nanoparticles, there is no need for a temporal resolution, so pulsed 
excitation and time-gated detection are not necessary. Even though UCPs require a 
rather high excitation intensity (1-103 W/cm2)176 there are convenient, powerful and 
cheap InGaAs/AlGaAs/GaAs laser diodes available at the appropriate wavelength of 
around 980 nm. 
So far many research groups have developed their own readers by adding a NIR laser 
diode to an existing plate reader253, spectrometer229, or microscope265, together with the 
appropriate filters. In some cases the whole instrument has been custom built267. These 
readers commonly utilize a photomultiplier tube as a detector, combined with the 
NIR-laser with a power ranging from 0.05-1 W253,267,269–271. Soukka et al270 have reported 
their reader of having an excitation intensity of over 40 W/cm2. Based on the spot size 
from Huang et al271, their instrument produced an intensity of 0.6 W/cm2  with a 50 
mW laser diode. For imaging a microarray in a microtiter well, Ylihärsilä et al272 
utilized a much more powerful laser with an output of 8 W and used a CCD-camera 
for the imaging of the anti-Stokes photoluminescence. 
Lately, a Qiagen ESEQuant -device equipped with a laser and photodiodes has been 
used to detect UCPs from lateral flow strip245. Being impressively small (165 × 178 × 46 
mm), lightweight (700 g), battery operated and indicating excellent field-robustness248, 
this instrument is a promising demonstration how UCPs could be used even with 
hand-held readers. However, as photomultiplier tubes are the most sensitive detectors 
available, the use of a photodiode is a compromise between portability and sensitivity. 
Comparison to UpLink reader has revealed that the sensitivity of the ESEQuant is an 
order of magnitude lower than the one of UpLink reader245. 
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3 AIMS OF THE STUDY 
The overall aim of the study was to explore ways of utilizing time-resolved 
fluorescence and anti-Stokes detection in POC applications. The study was focused on 
the excitation wavelength of an Eu(III) ligand, suitable for bioaffinity assays, and on 
the use of upconverting phosphors as an internal light source in glucose sensing test 
strips and the modulation of their emission. 
More specifically, the aims were: 
I To develop a bioaffinity assay compatible enhancement solution for Eu(III) 
ions that would be excitable at wavelengths where high power light emitting 
diodes are available. 
II To demonstrate the possibility of using upconverting phosphor particles as an 
internal light source in glucose sensing test strips. 
III To study the feasibility of using UV-emitting, nanosized UCPs as an internal 
light source in glucose sensing test strip, and to compare their performance to 
the use of an external UV light source. 
IV To study the use of microsized, visible emitting, upconverting phosphors as a 
signal amplifying component in a glucose sensing test strip by modulating 
their emission through the attenuation of the excitation and emission 
wavelengths. 
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4 SUMMARY OF MATERIALS AND METHODS 
A detailed description of the materials and methods employed in this study can be 
found in the original publications (I-IV). A brief summary with some additional 
information is presented here. 
4.1 Lanthanide labels 
4.1.1 Enhancement solution for Eu(III) 
The enhancement solution, that was studied in the original publication I, was based on 
the commercially available DELFIA enhancement solution (DES, Perkin-Elmer Life 
and Analytical Sciences - Wallac Oy, Turku, Finland)273 with the light harvesting 
ligand replaced with a 9-ethyl-3,6-bis(5′,5′,5′,4′,4′-pentafluoro-1′,3′-
dioxopentyl)carbazole (bdc, Figure 5 a). Its performance was compared against the 
original DELFIA solution that utilizes 2-naphthoyltrifluoroacetone (β-NTA, Figure 5 
b) as the ligand. 
 
Figure 5. The structures of the light harvesting ligands used in the original publication I. a) the 
bdc-ligand and b) β-NTA-ligand used in the commercially available DELFIA Enhancement 
Solution, which was the point of comparison. 
4.1.2 Upconverting phosphors 
The UV-emitting upconverting nanophosphors (UCNPs) used in the original 
publications II and III were composed of β-NaYF4:Yb3+,Tm3+, synthesized in the 
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presence of K+.274 The commercial particles used in publications II and IV were 
upconverting microphosphors (UCμP) with Er(III) as the activator ion. These UCPs 
were purchased from Honeywell specialty chemicals GmbH (Seelze, Germany). 
4.2 Reagent and strip preparation 
4.2.1 Preparation of the enhancement solution 
The composition of the bdc enhancement solution is based on that of the 
commercially available DELFIA Enhancement Solution, and was composed of 6.80 
mM potassium hydrogen phthalate buffering solution (adjusted to pH 3.2 with acetic 
acid), containing 7.50 μM bdc, 50.0 μM trioctylphosphine oxide  (TOPO) and 0.10% 
(v/v) Triton X-100. The solution was stored at +4 °C, protected from light. 
4.2.2 Preparation of the glucose sensing test strips 
The glucose sensing test strips were composed of two dry chemistry layers, coated on a 
plastic foil (Figure 6). The bottom layer contained the sensing components and the 
upper layer acted as a filter against the blood cells as well as a light reflecting layer. The 
UV-emitting UCNPs were located in the filtering (II and III) layer, and the VIS-
emitting UCμPs in the sensing layer (II and IV). 
 
Figure 6. The structure of a glucose sensing test strip. The filtering layer prevents the blood 
cells from entering the sensing layer where they would interfere with the measurement. The 
sensing layer contains the components required for the enzymatic reaction and the indicator 
compound. The UCPs were located either in the filtering (II and III) or sensing layer (II and 
IV). 
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All of the strips were prepared by dissolving/suspending all of the components in mQ-
water. Homogenous distribution was ensured by mechanical stirring, sonication and 
pressing the mixture through a fine mesh cloth. The final coatings were processed to a 
form of Accu-Chek® Active test strips shown in Figure 7. 
Strips with the UV-emitting UCNPs 
In the publications II and III, the composition of the strip sensing layer was as follows: 
Sensing layer: 101.1 g/L Sipernat FK 320DS (Evonik Industries AG, Hanau, Germany), 
8.1 g/L poly(acrylic acid) (average molecular weight ~15 000, Sigma-Aldrich, 
Steinheim, Germany), 15.3 g/L Gantrez S-97 BF (Ashland, Marl, Germany), 40.4 g/L 
Propiofan 70D Propiofan 70D (BASF, Ludwigshafen, Germany), 1.6 g/L Geropon T77 
(Rhodia, Milan, Italy), 64.7 g/L cNAD and 32.3 g/L glucose dehydrogenase (both from 
Roche Diagnostics GmbH, Penzberg, Germany) with pH adjusted to 7.5. 
 
To incorporate the UCNPs in the filtering layer, the oleic acid, bound on the UCNP 
surface during the synthesis, was washed away with hydrochloric acid275 to be replaced 
with the Gantrez-polymer. For this, the UCNP-particles were suspended to methanol 
with the polymer. After a uniform mixture was obtained, water was added and the pH 
adjusted with NaOH, until a homogenous suspension was formed. Methanol was then 
removed with a rotary evaporation to obtain the final concentrations of 65 g/L Gantrez 
and 300 g/L of UCNP. This mixture was then combined with the rest of the 
components for the filtering layer in the final concentrations of 411.6 g/L ZrO2 TZ-
3YS (Tosoh Corporation, Kaisei-cho, Japan), 8.7 g/L poly(acrylic acid), 54.1 g/L 
Propiofan 70D and 1 g/L Geropon T77. 
 
To test the use of uncoated nano- and microsized particles in these test strips, either 
the NaYF4:Yb3+,Tm3+ UCNP (with the oleic acid), or Honeywell UCμPs were 
embedded in the sensing layer. The UCPs were suspended in a aqueous suspension 
with poly(acrylic acid) in ratios (w/w) of 65 % UCP, 32 % water and 3 % poly(acrylic 
acid) without additional modifications. 
The coating masses were then coated on the plastic film (Bayfol CR210, 125 μm thick, 
Bayer MaterialScience AG, Leverkusen, Germany) using a manual blade coating. The 
sensing layer was coated to a height of 75 μm and. After drying in +35 °C for 15 
minutes, the second layer containing the UCNP was applied on top of this with a blade 
height of 100 μm and dried as the first one. 
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Strips with the VIS-emitting UCμPs 
The strips used in the original publications II and IV, containing the commercial 
Honeywell UCμPs with the PMo indicator dye, were standard Accu-Chek® Active 
strips, made with coating mixtures obtained from Roche Diagnostics GmbH 
(Mannheim, Germany). The UCμPs were first suspended in a aqueous suspension 
with poly(acrylic acid) in ratios (w/w) of 65 % UCP, 32 % water and 3 % poly(acrylic 
acid) without additional modifications and then combined with the coating mass for 
the sensing layer. This mixture was then applied on the supporting plastic foil (corona 
treated yellow pokalon N 343 EM film, LOFO High Tech Film, Weil am Rhein, 
Germany) in a thickness of 158 μm by blade coating. After drying, the second mixture 
was applied in a thickness of 73 μm and dried. 
4.3  Instrumentation 
4.3.1 Time-resolved detection of the Eu(III) fluorescence 
Time-resolved excitation and emission spectra as well as a fluorescence lifetime of 1 
μM Eu(III) in DES and bdc-based solution (I) were measured with a Varian Cary 
spectrofluorometer using an excitation slit of 5 nm. The measurement delay and 
integration window were set to 100 and 600 μs, respectively. The lifetime of the 615 
nm emission of Eu(III) in bdc-based solution was measured using either a 340 or 
400 nm excitation wavelength, and the ligand concentration was varied between 5 
and 40 μM. The lifetime of Eu(III) in DES was measured only with 340 nm 
excitation. 
Eu(III) signal in the bio-BSA assay (I) was detected with a Victor2 1420 multilabel 
counter (Perkin-Elmer Life and Analytical Sciences) using either a standard 340 or 
365 nm (365/30 nm, Ferroperm, Denmark) excitation filter with a 400 μs 
measurement delay and a 400 μs window together with the standard 615 nm 
emission filter. 
The molar absorptivities of the micellar complexes were calculated by measuring the 
absorbance of the complexed portion of the ligand in the enhancement solutions 
with 1 μM Eu(III) assuming that three ligand molecules are coordinated to one 
Eu(III) ion. The quantum yield of the micellar complex was determined according to 
the recommendations of IUPAC276 using a DES-solution with 1.0 μM Eu(III) as a 
reference that has the known quantum yield of 0.70.129 The lanthanide quantum 
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yields were determined as described by Xiao and Selvin277 using sulforhodamine 101 
as an acceptor in concentrations of 0.2, 0.6, and 1.0 μM. 
4.3.2 Detection of the anti-Stokes photoluminescence of UCPs 
The instrumentation used in the glucose assays (II-IV) was based on a Tidas S 
DAD -spectrometer (J&M Analytik AG, Essingen, Germany), equipped with a KG5 
bandpass filter (FGS600, Thorlabs, Munich, Germany) in the emission light path. 
This instrument was used to detect either UCP emission or reflectance from the 
test strips. The UCPs were excited with a 100 mW NIR-laser (RLD-0980-PFR 
LabSpec 980 nm, Laserglow technologies, Toronto, Canada). The internal light 
source of the spectrometer was used for the measurement of reflectance in the 
original publications II and III. In the publication IV, it was replaced by a separate 
50 W halogen lamp (LSB114/5, LOT-Oriel, Darmstadt, Germany) and an 
integrating sphere (K-050UV, LOT-Oriel) was used to collect the signal for the 
detector. 
4.4 Assays 
4.4.1 Bioaffinity assay for the comparison of Eu(III) enhancement solutions 
The applicability of the bdc-based enhancement solution was demonstrated in a 
heterogeneous, noncompetitive assay for biotinylated bovine serum albumin (bio-
BSA). A constant amount of Eu(III)-labeled streptavidin (Eu-SA) was used to detect 
different amounts of bio-BSA278 on the bottom of SA-coated microtiter wells. Either 
bdc-based enhancement solution or DES was used for the detection of Eu-SA. Briefly, 
dilutions from 0.0032 to 625 ng/well of bio-BSA were first incubated in streptavidin 
coated wells. After the wells were washed, Eu(III) labeled streptavidin was added. After 
incubation, the wells were washed, and enhancement solutions were added. Finally, 
the signal from Eu(III) was measured using a time-resolved detection under a 340 or 
365 nm excitation as described in section 4.3.1. Background signal was measured from 
a well that was not exposed to bio-BSA or Eu-SA, but contained the enhancement 
solution. 
4.4.2 Glucose assay with UCPs 
The measurement of blood glucose with test strips was based on an oxidoreductase 
enzyme embedded in the strip together with an indicator dye and the UCPs. The 
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enzyme oxidizes glucose to gluconolactone and the electron from this reaction is 
transferred to the indicator compound either directly (II and III), or via mediator 
compound (II and IV)238. This change in the oxidation state can then be observed as a 
change in the absorptivity that was used to attenuate the emission from the UCP-
particles. 
The UCP emission and the reflectance were both recorded at the range of 300-1000 
nm. When comparing the UCP measurement with reflectance, the strips containing 
UCP were used with both methods. The spectrum was recorded initially from a dry 
strip without any sample to obtain the reference signal and, subsequently, after the 
addition of the 5 μL sample of either glucose in water (II-IV) or whole blood spiked 
with glucose (II and III). 
The signal from the test strip (either UCP emission or reflectance) was analyzed as a 
relative signal. This was the percentage of the signal in the reaction endpoint, 
compared to the reference signal from the dry strip, before the addition of a sample. 
When using the UV-emitting UCNPs with cNAD as the indicator (II and III), the 
UV-emission (IUV 330-380 nm) was normalized with the control signal (Ictrl 440-490 
nm) by integrating both of the emission peaks, and calculating a ratiometric signal of 
IUV/Ictrl. In the case of reflectance, intensity at 362 nm was used. With the Honeywell 
UCμPs with PMo as the indicator (II and IV), intensities at wavelengths 549 and 670 
nm were used. In reflectance measurement, also the intensity at 978 nm was analyzed. 
The reaction endpoint was determined as a point on the kinetic curve where the slope 
was <2 %/s. 
Two different configurations were used in the measurement of UCP emission from the 
test strips (Figure 7). With the UV-emitting UCNPs (II and III), the excitation source 
was located either below or above the test strip (Figure 7, both configurations). When 
using the Honeywell UCμPs (II and IV), the excitation source was always below the 
strip (Figure 7, left side). Reflectance was always measured with a broad band light 
being shined to the strip from below (Figure 7, left side). 
 




Figure 7. The configurations used when measuring reflectance and UCP emission from the 
glucose sensing test strips. On the left side a is setup used for all of the reflectance and UCP 
measurements and, on the right, a setup where the UV-emitting UCPs were excited through a 
layer of whole blood. 
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5 SUMMARY OF RESULTS AND DISCUSSION 
5.1 Enhancement solution for Eu(III) ions (I) 
5.1.1 Characterization of the enhancement solution 
Excitation spectra of the europium chelates with the bdc-ligand from the original 
publication I (Figure 8) showed broad peaks in the 300−450 nm range, while DES has 
only one excitation peak at 340 nm from where the excitation efficiency decreases 
rapidly and is at the background level at 400 nm. The relative excitation efficiency of 
the bdc ligand in the 380−450 nm range compared to the 335 nm peak was affected by 
the concentration of the ligand. The excitation efficiency in this area increased with 
the increasing ligand concentration. There is no experimental data to explain what 
causes this, but we speculate that a high ligand concentration leads to a situation where 
a single ligand molecule participates in the chelation of only one Eu(III) ion whereas 
with lower ligand concentrations a single ligand may be attached to two separate ions. 
 
Figure 8. The excitation spectra of the enhancement solutions with a 5−40 μM bdc-ligand 
concentration and DES solution, both with 1 μM Eu(III). Different bdc-ligand concentrations 
are 5.0 μM (dash), 7.5 μM (dash dot), 10.0 μM (dash dot dot), 20.0 μM (dot), 40.0 μM (solid 
black), and DES (solid gray line). a.u., arbitrary unit. 
The higher signal level of the bdc ligand complex was due to the molar absorptivities 
of the micellar complex, that at 340 nm, were on average 2.5 fold higher than the one 
of DES. As the ligand concentration in the enhancement solution is increased from 5 
to 40 μM, the molar absorptivity at 405 nm rises from 44 000 to 68 000 M−1cm−1, 
respectively.  
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Quantum yields and fluorescence lifetimes of the micellar complex in different 
enhancement solutions with 1 μM Eu(III) produced almost identical results despite 
the enhancement solution used. The quantum yields with the bdc ligand 
concentrations from 5 to 20 μM ranged from 0.66 to 0.70, which is comparable to the 
one of DES (0.70). Bdc solution with a 40 μM ligand concentration was the exception 
with a lower quantum yield of 0.61. All of the bdc solutions had luminescence lifetimes 
between 738 and 757 μs that is practically the same measured for DES (743 μs). The 
excitation wavelength had no effect on the lifetime of the bdc enhancement solution, 
nor the relative emission intensities of the different Eu(III) emission peaks. 
Due to a higher background signal in the bdc-solution, the lowest detectable 
concentration of Eu(III) was not improved compared to DES under a 340 nm 
excitation (Table 1). However, the wider excitation range made it possible to move the 
excitation up to 365 nm without compromising the limit of detection of the assay. In 
addition, the higher molar absorptivity of the bdc-ligand produced 3.0 times higher 
emission intensity when excited at 365 nm, compared to DES excited at 340 nm. 
Table 1. Limits of detection and relative signal intensity for bio-BSA in the heterogenous assay 
using either DES of bdc-based enhancement solution when excited at 340 or 365 nm 
wavelength. 
 Relative intensity Limit of detection (fM) 
Enhancement 
solution 
340 nm 365 nm 340 nm 365 nm 
DES 1.0 0.4 32 190 
7.5 μM bdc 2.5 3.0 64 63 
 
5.1.2 Bioaffinity assay with europium label 
The 7.5 μM bdc-ligand concentration was chosen to be used in the proof of principle –
type of assay because it gave the highest signal with the plate reader (data not shown). 
In this heterogeneous assay, increasing the amount of bio-BSA in a microtitration well 
resulted in an increased binding of Eu(III) labeled streptavidin in a concentration 
dependent manner. Both enhancement solutions were able to produce a quantifiable 
(S/N > 3) signal from all the wells containing Eu(III)-SA, either due to the binding of 
Eu-SA through bio-BSA or a nonspecific binding. Using either DES with a 340 nm 
excitation or bdc-based enhancement solution with a 365 nm excitation resulted in the 
highest signal-to-noise (S/N) -ratios that were almost identical (Figure 9). This 
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indicates that the bdc-enhancement solution excited at 365 nm works equally well as 
DES excited at its optimal wavelength in the ligand binding assay. 
 
Figure 9. Signal-to-noise ratios obtained with the heterogeneous binding assay for biotinylated 
BSA using Eu(III)-labeled streptavidin as a tracer. The enhancement of Eu(III) was done by 
using either commercial DES or bdc-based enhancement solution. The different symbols 
represent DES with 340 nm excitation (filled squares), DES with 365 nm excitation (open 
squares), bdc with 340 nm excitation (filled circles), and bdc with 365 nm excitation (open 
circles). 
5.2 UCP-particles as an internal light source (II-IV) 
5.2.1 Reflectance of the test strips 
The emission spectra of the different UCPs under 980 nm excitation, measured from 
dry glucose sensing test strips, are presented in Figure 10. 
 
 




Figure 10. The upconversion emission spectra of the UCP-particles used in the original 
publications II-IV.  a) Nanosized NaYF4:Yb3+,Tm3+ (under a 2.4 W/cm2 excitation) and b) 
commercially available microsized Honeywell Lumilux (under a 0.87 W/cm2 excitation). The 
emission is presented with a solid line and the laser emission, used as an excitation source, 
plotted with a dashed line. a.u., arbitrary unit. 
The two indicators used in the original publications II-IV were carba-nicotinamide 
adenine dinucleotide (cNAD)279 and phosphomolybdenum blue (PMo, 
H6P2Mo18O62)280. The change in the test strip’s reflectance, caused by these indicators 
after the addition of glucose, is presented in Figure 11. 
 
Figure 11. The change in the reflectance of a glucose sensing test strip as a) cNAD or b) PMo 
indicator dye is reduced after the introduction of glucose sample onto the strip.  
5.2.2 Nanosized UV-emitting UCPs with cNAD as the indicator 
In the original publications II and III, the glucose assay was based on an indicator dye 
that has a narrow absorption in the UV-region as a result of being reduced after the 
introduction of glucose on the test strip. 
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This assay was first tested by using a solution of glucose in water as a sample. The 
detection setup was based on the traditional configuration, having a light being shined 
to the test strip directly from the opposite side of sampling, and detecting the change 
in the reflection. For the measurement of the emission from upconverting 
nanophosphors (UCNPs), a broadband light source was replaced with a 980 nm laser, 
and the emission from the UCNPs was detected.  
The results (Figure 12) obtained with different methods correlate well with the 
concentration of glucose in the sample if the internal control signal is used in the 
UCNP measurement. In terms of sensitivity and dynamic range, there is no noticeable 
difference between them. When the internal control of the UCNPs is omitted and only 
the UV-emission is used for the analysis, the standard deviations are significantly 
higher and the slope of the calibration curve lower. This is caused by the fluctuations 
in the UCNP-emission upon the addition of sample, caused by quenching, migration 
of the UCNPs in the test strip, and changes in the optical properties of the test strip. 
 
Figure 12. Results from the glucose assay with a light source below the strip and glucose 
dissolved in water as a sample. a) The glucose calibration curves obtained using either the 
emission of UCNPs (squares) or reflectance (spheres). The filled squares represent a 
ratiometric UCNP-signal and the open squares represent data obtained from the UV-emission 
of the UCNPs alone. The biexponential decay curve was used for the fitting. b) The correlation 
of the relative reflectance and ratiometric UCNP emission. The R2 values of all the fittings were 
> 0.99. The error bars represent standard deviation from five replicate measurements. 
To demonstrate the possibilities presented by the UCNPs to the design of optical 
setup, the excitation source was moved to the other side of the test strips and the assay 
repeated using a heparinized whole blood spiked with glucose as a sample. As human 
blood is relatively transparent for 980 nm radiation and the UCNPs provide an 
internal control signal, it was possible to measure the emission of UCNPs also in this 
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configuration. The same samples were then used also in a traditional reflectance based 
measurement to provide a point of comparison. Both measurements show a higher 
signal variation compared to the use of water and glucose as a sample, but the 
correlation between the two methods remains good (Figure 13). 
 
 
Figure 13. Results from the glucose assay with whole blood as sample. The UCNPs were 
excited through the sample and the reflectance was measured from the other side. a) The 
relative signals obtained from the UCNPs (squares) or reflectance (spheres) measurement. b) 
The correlation of the relative reflectance and ratiometric UCNP emission. R2 of the linear 
fitting is >0.99. The error bars represent standard deviation from five replicate measurements. 
5.2.3 Microsized, VIS-emitting UCP-particles as an internal light source with 
PMo indicator 
In the original publications II and IV, the test strips had an indicator dye with a broad 
absorbance covering both the emission and the excitation range of the UCμPs. 
The relative signals from the glucose measurement were plotted against the sample 
concentrations (Figure 14). The amplified response from the UCμPs in comparison to 
reflectance can be seen as a steeper calibration curve. This effect stems from the 
combined effect of filtering both emission and excitation wavelengths of the UCμPs. 
The relative signal ranges were almost doubled from 49 to 92 percentage points, when 
detecting the UCμP emission at 670 nm, compared to the measurement of reflectance 
at the respective wavelength. The slopes of the calibration curves at this wavelength 
were steepest at low glucose concentrations varying between 0.99-12 for the 
reflectance measurement and 1.1-36 for the UCμP measurement. It was also at the low 
glucose concentrations where the use of UCμPs made the highest improvement on the 
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slopes, up to three-fold. This difference decreases when the amount of glucose is 
increased and at 22 mM the slopes of the two methods are identical.  
 
Figure 14. a) The relative signals obtained from the glucose assay by detecting either 
reflectance or UCμP emission. The filled symbols represent UCμP and the open ones 
reflectance measurement. The different wavelengths are denoted as squares, diamonds and 
circles for 549, 670 and 978 nm, respectively. b) The correlation of the relative reflectance and 
ratiometric UCμP emission. The R2 values of all the fittings were > 0.99. The error bars 
represent standard deviation from ten replicate measurements. 
5.2.4 Summary of UCP as an internal light source in glucose sensing test strips 
Behavior of UCP particles in a test strip 
The UV-emitting, nanosized NaYF4:Yb3+,Tm3+ particles produce enough emission for 
the signal to be quantified, but this required long integration times from the 
instrumentation used in this work. These UCNPs are also rather sensitive to the 
interaction with the water molecules resulting in quenching when an aqueous sample 
was introduced to the test strip. Coating the UCNPs with a high molecular weight 
polymer minimized this effect (Figure 15 a). In comparison, the significantly larger 
particles from Honeywell produce significantly higher emission and most of the signal 
was retained without a need for additional coating (Figure 15 b). These particles have 
an average diameter of 1.0 μm, but the composition is not reported by the 
manufacturer. However, based on the anti-Stokes emission spectrum it can be 
concluded that they use erbium as an activator ion. When the emission of the 
nanosized NaYF4:Yb3+,Tm3+ particles (average size 75*90 nm) was measured from a 
test strip before and after the addition of water, the intensity of the detected signal 
went down by 78-96 % (depending on the wavelength). After the particles were coated 
with the high molecular weight Gantrez-polymer, the signal decrease was only 14-30 % 
(Figure 15 a). When the UCNPs in the strips were replaced with larger ones from 
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Honeywell, the signal decrease upon the addition of water was only 30 % (at 550-670 
nm, Figure 15 b). This result is identical to the one obtained with polymer coated 
nanosized UCNPs at 646 nm. This decrease in the signal is most likely due to optical 
properties of the strip changing upon wetting. 
 
Figure 15. The UCP emission spectra recorded from the test strip before (solid line) and after 
(dotted line) the addition of sample of water. a) Nanosized NaYF4:Yb3+,Tm3+ particles (under a 
2.4 W/cm2 excitation) are heavily quenched by water when not protected by a polymer, which 
minimizes this effect (dashed line). b) The larger particles from Honeywell (under a 0.87 
W/cm2 excitation) show a similar decrease in the signal as the polymer coated UCNPs without 
any additional modification. a.u., arbitraty unit. 
Assay performance 
The results from the glucose assays using different particles and different strips (II-IV) 
are compared to the respective reflectance measurement in Table 2. In both cases the 
use of UCPs as an internal light source on glucose sensing test strips lead to an 
improvement in the limit of detection, which was roughly two-fold lower than the one 
obtained with a reflectance measurement. With the larger Honeywell UCμPs, 
modulating the emission by attenuating the excitation lead also to a steeper calibration 
curve. However, the signal variation with the UCμPs is higher than with reflectance, 
but still significantly better than the CV% (coefficient of variation) in the 
measurement with the UV-emitting UCNPs, when the internal control signal is 
omitted. This indicates that the larger UCPs provide a more stable signal in the test 
strip than the nanosized ones. 
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Table 2. Summary of the results from using UCPs as an internal light source in glucose sensing 
test strips. 
 UV-emitting UCNPs 
(NaYF4:Yb3+,Tm3+) 
with cNAD indicator 
VIS-emitting UCμPs (unknown 
composition with Er3+) 










361 nm (FWHM ~40 nm)279 
Broad 
~550 to over 1000 nm 
Detected 
wavelength 





930 μM 490 μM 11.9 μM 5.7 μM 
CV% 0.92-9.1 0.64-6.7 
(2.9-21)b 
0.63-2.1 0.95-9.4 
Slope of the 
calibration curve 
0.61-12 0.66-11 0.99-12 1.1-36 
a 362 nm was attenuated by the indicator dye and 478 nm was used as an internal control 
signal. 







Point-of-care –diagnostics is a rapidly growing segment of in vitro diagnostics with a 
pressure to push the performance of the assays constantly further. As the benefits of 
lanthanide photoluminescence have been well established in several diagnostic 
applications, it might well be a useful tool also in the improvement of POC assays. 
In this thesis, ways of utilizing time-resolved and anti-Stokes detection in POC were 
explored. Time-resolved fluorometry was studied by developing a novel enhancement 
solution for Eu(III)-ions that would be applicable in bioaffinity assays. Anti-Stokes 
detection was utilized by using upconverting phosphors as an internal light source in 
blood glucose sensing test strips. 
The main conclusions based on the original publications are presented below. 
I An enhancement solution based on a novel light harvesting ligand enabled the 
efficient excitation of Eu(III)-ions and produced a high signal in a bioaffinity 
assay. The new enhancement solution was also excitable in the wavelength 
range where high power light emitting diodes are available. The high emission 
intensity, produced by the ligand, is beneficial when attempting to overcome 
the limitations brought by the low excitation power and detection sensitivity 
of miniaturized components essential for various POC devices. 
II Different kind of upconverting phosphors were found to be a feasible 
alternative to be used as an internal light source in glucose sensing test strips. 
The modulation of the detected UCP emission with a redox-indicator 
compound was found to be an alternative way of detecting glucose in sample 
solution and several wavelengths of the UCPs could be utilized for this 
purpose. 
III UV-emitting UCNPs could be used as an internal light source in glucose-
sensing dry chemistry test strips to replace an external UV light source with a 
NIR-laser. They also provided an additional degree of freedom on the design 
of the optical setup of the instrumentation. The results were comparable to a 
commonly used reflectance measurement. 
IV The use of VIS-emitting UCμPs as an internal light source in glucose sensing 




manipulating the slope of the assay calibration curve. By utilizing the non-
linear relationship between the excitation power and the emission intensity of 
the UCμPs, they can be used as a signal-amplifying component for a NIR-
absorbing indicator dye. 
As discussed in the literary review, the lack of compact instrumentation is a 
considerable obstacle in the use of lanthanide labels in POC applications. However, the 
research with the UCPs has been focused on producing increasingly smaller particles 
and it seems that the potential of larger crystals has been somewhat overlooked, as 
there does not seem to be well-established methods of synthesizing monodisperse 
particles with a diameter of over 200 nm. As larger particles have higher luminescence 
output and might be suitable for various applications, they could be an important 
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